Back
OSLO
Oncosil Medical Ltd
🇦🇺 ASX
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
N/A
Annual Growth
5 years average annual capital growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
0
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Oncosil Medical Ltd - Option Expiring 30-Apr-2027
📈 Performance
Price History
N/A
1M
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.00
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in OSLO
0
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in OSLO
N/A
OSLO investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
👶 Age of investors
18 - 25
26 - 34
35 - 90
🙋 Legal gender of investors
Female
Male
Pearlers who invest in OSLO also invest in...
Want more shares? Try these...
Osmond Resources Ltd. operates as an early-stage mineral exploration and development company. The company is headquartered in Melbourne, Victoria. The company went IPO on 2022-04-22. The firm is focused on gold and base metals discoveries within projects located in South Australia and Victoria. Its projects are focused on exploration for gold, nickel, copper, and rare earth elements (REE) within the Fowler Domain and Nuyts Domain. Its Yumbarra Project is located in the western Eyre Peninsula region of South Australia within the Nuyts Domain of the Gawler Craton. The Company’s Fowler Project has two adjoining tenements located on the eastern margin of the Fowler Domain in the far west of South Australia. Its Coorabie Shear Zone Project is located on the eastern margin of the Fowler Domain in the far west of South Australia and is contiguous with the Fowler Tenements. The Company’s Tallacootra Project is located on the western margin of the Fowler Domain in the far west of South Australia. Its Sandford Project is located approximately 350 kilometers west of Melbourne.
📊 Share price
$0.16 AUD
OncoSil Medical Ltd. develops and commercializes neurology services, including those for pancreatic cancer. The company is headquartered in North Sydney, New South Wales. The company went IPO on 2005-08-15. OncoSil is a single-use brachytherapy (internal radiation) device used to deliver a pre-determined dose of beta radiation directly into cancerous tissue. OncoSil is comprised of Microparticles that contain a radioisotope and a specially formulated Diluent, which acts as a carrier to facilitate the implantation of the Microparticles into the target tissue. OncoSil is indicated for the treatment of patients with locally advanced unresectable pancreatic cancer, in combination with gemcitabine-based chemotherapy. The OncoSil System is supplied sterile and is intended for single-patient, single-use. OncoSil is approved in the various jurisdictions, including European Union, United Kingdom, Hong Kong, Singapore, Malaysia, New Zealand and Switzerland.